Zustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 184,92
Anzahl: 10 verfügbar
In den WarenkorbZustand: New.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 207,96
Anzahl: 1 verfügbar
In den WarenkorbHRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Zustand: As New. Unread book in perfect condition.
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
EUR 218,22
Anzahl: 1 verfügbar
In den Warenkorbhardcover. Zustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 220,50
Anzahl: 10 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
EUR 188,87
Anzahl: 1 verfügbar
In den WarenkorbZustand: NEW.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 233,88
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
Zustand: New.
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Erstausgabe
Zustand: New. 2025. 1st Edition. hardcover. . . . . .
Sprache: Englisch
Verlag: Apple Academic Press Inc., CA, 2025
ISBN 10: 1998511804 ISBN 13: 9781998511808
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes Königreich
EUR 276,84
Anzahl: 1 verfügbar
In den WarenkorbHardback. Zustand: New. Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance.The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New.
Zustand: New. 2025. 1st Edition. hardcover. . . . . . Books ship from the US and Ireland.
Sprache: Englisch
Verlag: Apple Academic Press Inc., CA, 2025
ISBN 10: 1998511804 ISBN 13: 9781998511808
Anbieter: Rarewaves.com UK, London, Vereinigtes Königreich
EUR 263,42
Anzahl: 1 verfügbar
In den WarenkorbHardback. Zustand: New. Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance.The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 331,99
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 462 pages. 9.18x6.12x10.00 inches. In Stock.
Sprache: Englisch
Verlag: Apple Academic Press Inc., Oakville, 2025
ISBN 10: 1998511804 ISBN 13: 9781998511808
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Hardcover. Zustand: new. Hardcover. Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance.The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis. Covers topics, from drug resistance to using AI to enhance treatment methods for TB. Explore TB diagnosis methods, drug resistance mechanisms in TB, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Sprache: Englisch
Verlag: Apple Academic Press Inc., Oakville, 2025
ISBN 10: 1998511804 ISBN 13: 9781998511808
Anbieter: CitiRetail, Stevenage, Vereinigtes Königreich
EUR 184,93
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: new. Hardcover. Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance.The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis. Covers topics, from drug resistance to using AI to enhance treatment methods for TB. Explore TB diagnosis methods, drug resistance mechanisms in TB, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 269,99
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 462 pages. 9.18x6.12x10.00 inches. In Stock. This item is printed on demand.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Covers topics, from drug resistance to using AI to enhance treatment methods for TB. Explore TB diagnosis methods, drug resistance mechanisms in TB, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance.
Sprache: Englisch
Verlag: Apple Academic Press Inc., Oakville, 2025
ISBN 10: 1998511804 ISBN 13: 9781998511808
Anbieter: AussieBookSeller, Truganina, VIC, Australien
Hardcover. Zustand: new. Hardcover. Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance.The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis. Covers topics, from drug resistance to using AI to enhance treatment methods for TB. Explore TB diagnosis methods, drug resistance mechanisms in TB, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Anbieter: preigu, Osnabrück, Deutschland
Buch. Zustand: Neu. Recent Advancements in Tuberculosis Drug Discovery | Vivek P. Chavda (u. a.) | Buch | Einband - fest (Hardcover) | Englisch | 2025 | Apple Academic Press | EAN 9781998511808 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.